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A THREE-CHOICE DRUG DISCRIMINATION PROCEDURE
DIFFERENTIATES THE STIMULUS EFFECTS
OF d-AMPHETAMINE AND MDMA
Amy K. Goodwin, M.A.
Western Michigan University, 1999
(±)-3,4-Methylenedioxymethamphetamine (MDMA) produces effects in
humans that are reportedly similar to those of CNS stimulants. However, drug
discrimination studies in nonhumans have yielded inconsistent results regarding the
similarities between MDMA and d-amphetamine. Sixteen male Sprague-Dawley rats
were trained to discriminate d-amphetamine, MDMA, and saline in a three-lever drug
discrimination procedure. In addition, differential outcomes were employed during
drug discrimination training with eight of the rats but this did not appear to facilitate
the acquisition of the discrimination. Cocaine (0.25-10.0 mg/kg) produced dose
dependent increases in d-amphetamine-appropriate responding with complete
substitution at the highest dose administered. LSD (0.02-0.16 mg/kg), produced dose
dependent increases in MDMA-appropriate responding and nearly complete
substitution (78%) at the 0.08 mg/kg dose. Fenfluramine (1.0-4.0 mg/kg), (+)MDA
(0.375-1.5 mg/kg), and (-)MDA (0.375 mg/kg), all produced dose-dependent
increases in MDMA-appropriate responding. The serotonin antagonist Pirenperone
(0.16-0.64 mg/kg) partially blocked the stimulus cue of MDMA.
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INTRODUCTION
The Drug Discrimination Procedure
Drug discrimination procedures are frequently used to classify the stimulus
properties of psychoactive drugs. Stimulus control refers to "instrumental behavior
under the control of particular stimuli that are present when the response is
reinforced" (Domjan & Burkhard, 1993, p. 221). Stimuli used in the study of
stimulus control can be divided into two categories: interoceptive (internal stimuli or
private events such as pain) and exteroceptive (environmental stimuli such as tones or
lights). In the drug discrimination procedure, drugs serve as internal discriminative
stimuli, signaling when a particular behavior will be reinforced. That is, following
repeated sessions where reinforcement has been available to the subject after
administration of a drug, the detection of the presence of that drug serves as a signal
to the subject that reinforcement is available. Generally, drug discrimination studies
employ a two-choice operandum where subjects receive a psychoactive drug or
vehicle (i.e., saline). In order to receive a reinforcer (e.g., water in a water deprived
subject), subjects are required to perform one behavior in the presence of the
psychoactive drug (e.g. press one lever) and a different behavior when the presence of
drug is not detected (e.g., press a different lever).
D'Mello and Stolerman (1978) reported that, generally, all drugs of abuse and
most psychoactive drugs demonstrate discriminative control. A subject may be said
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to have learned the discrimination task when condition-appropriate responding prior
to the presentation of the first reinforcer is 80% or better for a predetermined number
of consecutive sessions (e.g. 8 out of 10 consecutive sessions).
Once subjects have met the criterion for discrimination, other psychoactive
drugs may be administered to examine if these other drugs possess similar
discriminative stimulus properties to the training drug. This testing procedure is
usually performed under extinction conditions. That is, subjects are removed from
the operant chamber prior to the delivery of any reinforcement. Generally, if the
resulting behavior is 80% or greater responses on a drug-appropriate lever during the
testing sessions, then that substance is said to produce "substitution". "Substitution"
refers to the idea that the novel substance produces generalization to one of the
training conditions, indicating that it has similar stimulus properties. Additionally,
an antagonist drug may be administered prior to the training drug to determine if such
a compound will disrupt the stimulus control exhibited by the training drug. An
antagonist is said to have "blocked" the effects of a training drug if the result is 80%
or greater vehicle-appropriate responding. Antagonist testing is often used to study
the neural mechanisms involved in producing the discriminative stimulus effects of
psychoactive drugs.
However, there are limitations to consider when utilizing the drug
discrimination paradigm. It is difficult to interpret results if testing procedures
produce between 20% and 80% drug-appropriate responding, what is called "partial
substitution". This result may be interpreted as the subject responding on a sort of
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continuum of drug effect where the percent responding represents a description of the
level of drug effect but this has not been experimentally tested (Colpaert, 1987).
When subjects respond on the vehicle-appropriate lever after administration of
a testing compound, one may not conclude the stimulus effects of this compound are
necessarily opposite those of the training compound (Seiden & Dykstra, 1977), only
distinctly different. Thus, regardless of the stimulus properties of a particular
compound, the nature of the drug discrimination assay results in subjects responding
regardless of the effects experienced. Researchers must be cautious in their
interpretations of results obtained when using the drug discrimination assay, as it
essentially measures the subjective effects of drugs.
Various methods have been employed in an attempt to compensate for these
limitations. One such method is the utilization of more complex discriminations,
such as three-choice discriminations, or drug versus drug discriminations (Stolerman,
1993, chap. 9). Moreover, despite the limitations, the drug discrimination assay
serves as a useful tool to describe drugs as similar or dissimilar to training
compounds, as well as to examine neural mechanisms involved in the effects of
psychoactive drugs (Appel & Cunningham, 1986).
Drug Discrimination Investigations of l'vIDMA and Amphetamine
The psychoactive drug (±)-3,4 methylenedioxymethamphetamine (l'vIDMA)
is a commonly abused drug reported to amplify self awareness, and promote empathy
and communication (Solowij, Hall & Lee, 1992). l'vIDMA shares both amphetamine
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and (+)-lysergic acid diethylamide (LSD) properties although hallucinations are not
often experienced by users (Downing, 1986). MDMA is a structural analog to
d-amphetamine. However, human reports describe the subjective effects of MDMA
as distinctly different from those of psychostimulants (Grinspoon & Bakalar, 1986;
Solowij, Hall, & Lee, 1992). Those individuals surveyed reported MDMA primarily
produces euphoria, an increase in feelings of intimacy and empathy, as well as
intensified sensations and perceptions (Solowij et al., 1992). However, stimulant-like
effects were also reported. These include, motor restlessness, tremors, ataxia, and
sympathomimetic effects such as tachycardia and an increase in sweating (Solowij et
al., 1992). It is likely that MDMA possesses complex stimulus properties that make it
difficult to classify into the traditional drug classes (Baker & Taylor, 1997; Nichols,
1986; Nichols, Hoffman, Oberlander, Jacob, & Shulgin, 1987). Indeed, Nichols
(1996) has proposed a separate class to characterize MDMA and similar
amphetamines, for which he has coined the term "entactogens".
Investigations of the stimulus generalization between MDMA and
d-amphetamine have yielded conflicting results. Glennon and Young (1982) reported
that in rats trained to discriminate d-amphetamine from saline, (±)-MDMA produced
stimulus generalization. The generalization of (±)-MDMA to d-amphetamine in
pigeons was also reported by Evans and Johanson (1986). However, Oberlander and
Nichols (1988) failed to replicate these findings in rats. In addition, at least two
studies reported that animals trained to discriminate MDMA from saline do not
generalize to d-amphetamine (Glennon & Misenheimer, 1989; Schecter, 1987).
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Baker and Makhay (1994) reported partial substitution ofamphetamine in MDMA
trained rats. Interestingly, after administration ofa neurotoxic dose regimen of
fenfluramine, the highest dose ofd-amphetamine tested (1.0 mg/kg) produced
stimulus generalization. Moreover, Oberlander and Nichols (1988) reported that in
animals trained to discriminate (±)-MDMA from sal1ne, d-amphetamine did produce
stimulus generalization but at a dose that severely suppressed responding in halfof
the subjects. Table 1 presents a synopsis ofresults from drug discrimination
investigations ofMDMA and d-amphetamine.
In an attempt to further characterize the discriminative stimulus effects of
MDMA, Baker and Taylor (1997) utilized a three-choice discrimination procedure in
which rats were trained to discriminate d-amphetamine and LSD from saline. They
reported that neither isomer ofMDMA substituted for d-amphetamine and actually
produced more responding on the LSD-appropriate lever. These results indicate that
MDMA produces discriminative stimulus effects that are distinctly different from
those ofd-amphetamine and may in fact be more similar to LSD. Moreover, it
appears that the three-lever drug discrimination procedure is a more sensitive
behavioral assay in which to investigate the discriminative stimulus effects ofdrugs
with compound stimulus properties (Baker and Taylor, 1997). One ofthe aims ofthe
present study was to determine whether rats could be trained to discriminate MDMA
from d-amphetamine in a three-choice discrimination procedure.
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The Differential Outcomes Effect
Goeters, Blakely, and Poling (1992) reported that differential outcomes
shorten the time needed for acquisition of a response and also increase the terminal
accuracy of the response. Differential outcomes refers to correlating each
discriminative stimulus with a unique outcome. The efficacy of the differential
outcomes effect is well established. Trapold (1970) first demonstrated a shortened
time period for response acquisition and better accuracy in rats exposed to differential
outcomes in a two-choice discrimination. Utilizing a standard two-lever operant
chamber, a response on one lever was followed with one outcome (i.e., solid food)
and a response on a different lever was followed by a different outcome (i.e., sucrose)
(Trapold, 1970).

Others have employed this assay with various experimental

designs and numerous types of subjects (Goeters et al., 1992). Morgan and Baker
(1997) demonstrated that differential outcomes increased the acquisition speed of the
discrimination of cocaine from saline in rats. However, as Goeters et al. reported, the
efficacy of the differential outcomes effect has not been thoroughly established when
employed in experimental designs requiring subjects to respond to interoceptive
discriminative stimuli (e.g., drug discrimination assay). Moreover, Goeters et al.
reported that the usefulness of the differential outcomes effect appears to increase as
the difficulty of the task increases. Thus, examination of the utility of the differential
outcomes effect in a complex drug discrimination would be beneficial to researchers
in this vast field.

7
Purpose of the Present Study
The primary goal of the present study was to determine whether rats could
learn to discriminate the stimulus effects of both (±)-MDMA and d-amphetamine in a
three-choice drug discrimination procedure, and to determine whether differential
outcomes paired with each stimulus condition would facilitate the acquisition of this
complex drug discrimination.

METHODS
Subjects
Sixteen experimentally naive, male Sprague-Dawley rats served as the
subjects. The subjects were individually housed in wire mesh cages, in a colony
maintained on a 12-h light (0700 to 1900)/ 12-h dark cycle, at a consistent
temperature of 20-22° C and at a constant humidity of 70-80%. Subjects had free
access to standard laboratory rat chow. Access to water was restricted to 15-20 min
following training and testing sessions and to a 24 hour period on weekends. The
experimental protocol was reviewed and approved by the Institutional Animal Care
and Use Committee of Western Michigan University and the subjects were
maintained according to the general principles of animal husbandry outlined by the
National Institutes of Health (see Appendix A).
Apparatus
Eight standard operant chambers (MED Associates Inc., St. Albans, VT,
ENV-001) were used for all training and testing procedures. The operant chambers
were located within sound and light attenuating shells with ventilation and masking
noise. A 28 v house light was located in the front panel above the center lever. The
dipper (0.1 ml) used to deliver the reinforcer was located below the center lever.
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Drugs
The cl-amphetamine sulfate; (±)-MDMA hydrochloride; cocaine
hydrochloride; (+)-lysergic acid diethylamide (LSD); fenfluramine hydrocholoride;
and both isomers of 3,4-methylenedioxyamphetamine hydrochloride (MDA) were
obtained from the National Institute on Drug Abuse (Rockville, MD). Pirenpirone
was purchased from Research Biochemicals International (Natick, MA). All drugs
were dissolved in 0.9% bacteriostatic sodium chloride. Additionally, a few drops of
acetic acid was added to dissolve the pirenperone in the saline vehicle.
Training Procedures
Subjects were trained to discriminate cl-amphetamine (1.0 mg/kg) and
(±)-MDMA (1.5 mg/kg) from saline in a three-lever drug discrimination under a
fixed-ratio 10 (FR 10) schedule of liquid reinforcement. Injections were given
intraperitoneally (IP), with a presession interval of 15 min.
An auto shaping procedure was utilized for the first week of training. Subject
received between 5 and 6 sessions and no substance was administered prior to these
sessions. Additionally, only the center lever was present in the operant chambers
during this period of autoshaping. Following the autoshaping procedure, errorless
discrimination was employed. That is, only the condition-appropriate lever was
present for alternate training sessions of saline and each drug administration until
each subject was exposed to at least four errorless discrimination training sessions
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under each ofthese three conditions. At this point all three levers were introduced to
each subject and were present for the remaining training sessions for the duration of
the study. Training began with a FR 1 schedule ofreinforcement for each condition
and the ratio was gradually increased to 10 as responding became stable.
Reinforcement was contingent on 10 consecutive responses on the condition
appropriate lever, responses on any other lever reset the response counter and
reinforcement was not delivered until 10 consecutive responses were made on the
condition-appropriate lever. With administration ofd-amphetamine, half ofthe
subjects in both groups were reinforced for responses on the left lever and half were
reinforced for responses on the right lever. Conditions were reversed for
administration of(±)-l\1DMA. Under saline conditions, all subjects were reinforced
for responses on the center lever. All levers were wiped with isopropyl alcohol
between training sessions to reduce the effects ofolfactory cues in the operant
chambers (Extance and Goudie, 1981 ). Additionally, the order ofgroups was
occasionally reversed for training sessions.
Eight ofthe sixteen rats were in the differential outcomes group where
(±)-l\1DMA and d-amphetamine were correlated with either plain sweetened
condensed milk or chocolate flavored sweetened condensed milk as reinforcers.
Saline was correlated with water for all subjects in the differential outcomes group.
The control group received water, plain and chocolate sweetened condensed milk on
a random basis.
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Saline, (±)-MDMA, and d-amphetamine were administered in a random order
with subjects never receiving one condition for more than two consecutive sessions.
Training sessions lasted for 20 min and were conducted six days a week at
approximately the same time every day.
Testing Procedures
When subjects met the criterion for discrimination(80% ofresponses on the
condition-appropriate lever prior to the delivery ofthe first reinforcer for at least 8 out
of10 consecutive training sessions), stimulus generalization tests were administered
with three different doses ofeach training drug(±) MDMA 0.375-1.5 mg/kg;
d-amphetamine 0.25-1.0 mg/kg). Additionally, other test compounds(cocaine 1.010.0 mg/kg; LSD 0.02-0.16 mg/kg; fenfluramine 1.0-4.0 mg/kg;(+) MDA 0.375-1.5
mg/kg; and(-)MDA 0.375-3.0 mg/kg were tested for stimulus generalization.
Stimulus generalization tests were conducted in a manner similar to training sessions,
except no reinforcers were delivered and the animals were removed from the operant
chambers immediately upon completion of10 consecutive responses on any lever.
Antagonist tests were also conducted. The pirenperone(0.16-0.64 mg/kg) was
administered in conjunction with MDMA using a one hour preinjection period. That
is, the pirenperone was administered one hour prior to the testing session, the MDMA
was then administered fifteen minutes prior to the session.
Test sessions were conducted once or twice per week in place oftraining
sessions provided the animals maintained 80% or better responding on each
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condition-appropriate lever during training sessions. Following test sessions, animals
received 20-30 min free access to water in their home cages.
Data Analysis
The number ofsessions to criterion was calculated and a between-group
comparison was made. Additionally, test data from the two groups (i.e., control and
differential outcomes) were compared.
The mean percent oftotal responses on each lever for test sessions was
calculated and displayed for visual analysis for each condition (i.e., (±)-MDMA,
d-amphetamine, and saline). Rate was expressed as mean number ofresponses per
second. Test data from animals that did not complete the FR 10 requirement were not
included in the data analysis oftesting sessions. For testing sessions, complete
stimulus generalization was defined as at least 80% responding on either lever. For
drugs that produced substitution, nonlinear regression analyses were calculated to
determine ED50 s. Two way ANOVAs (group, dose) were conducted on each set of
dose response data.

RESULTS
All sixteen subjects acquired the discrimination (minimum of 80% condition
appropriate responses prior to delivery of the first reinforcer in at least eight of ten
consecutive training sessions) in the present experiment. Surprisingly, differential
outcomes during training did not appear to facilitate acquisition of the discrimination.
By 80 sessions, seven rats in the control group and six rats in the DO group had met
the discrimination criterion. A t-test on the number of sessions to criterion at this
point showed no significant difference between the two groups (t = 0.11, df=l 1, p >
0.10). The differential outcomes group met the discrimination criterion within 61
(SEM = 5. 7, Range: 42-80, n=6) sessions, and the control group met this criterion
within 60 (SEM = 2.9, Range: 53-74, n=7) sessions. Therefore, differential outcome
training was discontinued. All sixteen subjects met the discrimination criterion
before stimulus generalization testing began.
Figure 1 illustrates the results of stimulus generalization tests with MOMA.
This training drug produced dose-dependent increases in the percentage of responses
on the MOMA-appropriate lever and dose-dependent decreases in the percentage of
responses on the saline-appropriate lever (ED so=1.0 mg/kg). Very few responses were
emitted on the d-amphetamine-appropriate lever during stimulus generalization tests
with MOMA. A slight dose-dependent increase in response rate was observed.
However, differences in response rate among doses were not statistically significant.
13

14

MOMA
0

100

� 80

0
0-.

VJ

60

ffi

40

o..

20

,0
,
,,,

.,

,,

-0•%MDMA
..... % AMPHETAMINE
-0-% SALINE

0
0.0

0.38

0.75

1.5

DOSE (mg/kg)

0.0

0.0

0.38

0.75
Dose (mg/kg)

Figure 1. Results ofMDMA Dose-Response Tests.

1.5

15
Additionally, a difference in percent :rvIDMA-appropriate responding between the
control group and the differential outcome group was observed (F 1, 56=6.09, p<0.05).
Figure 2 illustrates the :rvIDMA dose-response curves for the differential outcome and
control groups, and the response rate ofboth groups. There was no difference in
response rates between groups. Two-way ANOVA's revealed no significant main
effects ofgroup on any ofthe other stimulus generalization tests.
The results ofstimulus generalization tests with cl-amphetamine are displayed
in Figure 3. This training drug produced dose-dependent increases in the percentage
ofresponses on the cl-amphetamine-appropriate lever and dose-dependent decreases
in the percentage ofresponses on the saline-appropriate lever (ED50=0.33 mg/kg). At
the training dose of cl-amphetamine (1.0 mg/kg), virtually no responses were emitted
on the MDMA-appropriate lever. It is interesting to note that the lowest dose ofd
amphetamine (0.25 mg/kg), five ofthe 16 subjects emitted between 30 and 100% of
their responses on the MDMA-appropriate lever. There was no statistically
significant dose effect on response rate. However, there was a significant effect of
group on response rate. That is, the control group responded at a higher rate then did
the differential outcome group. (F1,s6 =4.82, p<.05). Figure 4 illustrates the dose
response data and response rate data for the differential outcome and control groups.
Statistical analysis resulted in no other significant differences between the control and
differential outcome groups.
The administration ofcocaine produced a dose-dependent increase in
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d-amphetamine-lever responding with complete stimulus generalization at the highest
dose (10 mg/kg; EDso= 3.12 mg/kg; see Figure 5). There was no significant
difference in response rates across doses.
LSD produced nearly complete substitution (78%) for MDMA (see Figure 6).
Ofthe 16 animals tested, 12 exhibited complete stimulus generalization at the 0.08
mg/kg dose, one exhibited partial generalization (58%) and three exhibited
predominantly saline-appropriate responding (EDso=0.04 mg/kg). Fourteen rats were
tested at 0.16 mg/kg LSD, but this did not increase MDMA-appropriate responding.
The highest rate ofresponding was seen at the lowest dose ofLSD (0.02 mg/kg) with
a dose-dependent decrease in responding.
The serotonin releaser fenfluramine produced nearly complete substitution for
MDMA (see Figure 7) at a dose of2.0 mg/kg. Eight ofthe 10 animals that tested at
this dose exhibited complete generalization to MDMA (ED5o=0.56 mg/kg). Because
ofthe high percentage ofMDMA appropriate responding at the 2.0 mg/kg does, a
dose of4.0 mg/kg was administered. Response rate was severely depressed at this
dose. Only two ofthe nine animals tested at the 4.0 mg/kg dose completed the 10
required response. Both ofthese subjects exhibited complete substitution for
MDMA. Ofthe remaining seven animals, two subjects made six responses each, all
of which were on the MDMA-appropriate lever. However, only the data from the
two subjects that completed the test session were included in the data analysis.
Both isomers ofMDA were also tested for stimulus generalization. (+)-MDA
substituted completely for MDMA (see Figure 8) at a dose of1.5 mg/kg (ED50=0.70
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mg/kg). Response rates decreased in a dose-dependent manner. The administration
of (-)-MOA resulted in partial substitution at a dose of 1.5 mg/kg. A dose of3.0
mg/kg was then administered to nine subjects and five of the subjects completed the
required 10 responses. Complete stimulus generalization was exhibited by this dose
in these animals (ED 50=2. l 7 mg/kg; see Figure 9).
Figure 10 illustrates the results of the administration of the serotonin
antagonist pirenpirone in conjunction with MOMA. The result was a dose-dependent
decrease in MOMA-appropriate responding. However, the highest dose tested (0.64
mg/kg) did not produce complete blockade (42 %) of the MDMA cue. The highest
degree ofblockade was observed with the 0.32 mg/kg dose (56%). Response rate
differed very little across doses of pirenperone.
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DISCUSSION
The present results indicate that MDMA produces discriminative stimulus
effects that are distinctly different from those produced by the psychostimulant
d-amphetamine. In fact, MDMA appears to produce discriminative stimulus effects
that are more similar to those of the hallucinogen LSD. Moreover, these results are
consistent with reports from humans that the ingestion ofMDMA ("ecstasy") results
in effects that are dissimilar to those of psychostimulant drugs (Grinspoon & Bakalar,
1996; Solowij, Hall, & Lee, 1992).
Although Goeters et al. (1992) reported that differential outcomes shorten the
time needed for acquisition of a response, the results of the present study did not
support these findings. Possible flaws in the experimental design may account for
this finding. Although subjects were water deprived, outcomes consisted of diluted
plain and chocolate sweetened condensed milk with the administration of drug, and
water with the administration of saline. Moreover, perhaps the outcomes were not
distinct enough to produce an effect. Interestingly, a difference in the MDMA
stimulus generalization gradient was noted between the differential outcomes group
and the control group. The data for the dose-response curves was generated after
differential outcome training had been discontinued and subjects had again met
criterion for discrimination. Thus, it would appear that the history of differential
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training may have effected the data. A similar, but not significant, trend was
observed in the d-amphetamine dose-response data. Additionally, a difference
between the two groups in response-rate was significant. Overall, the utility of
differential outcomes in the drug discrimination procedure is still not well established.
Indeed, if the use of differential outcomes produces a more rapid rate of acquisition
and an increase in the terminal accuracy of the response, it would prove to be useful
in the drug discrimination assay, particularly in more complex discriminations (e.g.
three-lever discriminations). The possible effects of differential outcome training on
stimulus control of psychoactive compounds should also be further investigated.
It is well documented that rats exhibit stimulus generalization of cocaine to
d-amphetamine, and conversely, the generalization of d-amphetamine for cocaine
(Brauer, Goudie, and de Wit, 1997). The results of the present study support these
findings. Numerous studies have illustrated that cocaine and d-amphetamine produce
stimulus effects primarily through their actions on dopamine (DA) (Goudie, 1991; Ho
and Huang, 1975; Nielsen and Jepsen, 1985; Wise, 1984; Woolverton, 1984; Young
and Wise, 1975, 1976). The results of the present study support the role of DA in the
stimulus effects of d-amphetamine. Although MDMA is also a potent DA releaser,
the present data indicate that its discriminative stimulus effects are clearly dissociable
from those of d-amphetamine. This suggests that MDMA' s discriminative stimulus
effects are not solely mediated by DA, but may also involve other mechanisms.
The fact that LSD produced nearly complete substitution for MDMA in the
present study suggests that the discriminative stimulus effects ofMDMA involve
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serotonergic mechanisms. The role of serotonin in LSD discrimination is well
documented (Appel, Baker, Barrett, Broadbent, Michael, Riddle, and Groll, 1991;
Cunningham and Appel, 1987). Although group statistics did not illustrate complete
generalization to (±)-MDMA when LSD was administered, eleven ofthe sixteen
subjects responded at 90% or greater on the MDMA appropriate lever at the 0.08
mg/kg dose. Oberlander and Nichols (1988) reported that in rats trained to
discriminate (±)-MDMA from saline, LSD produced only partial generalization.
Baker, Broadbent, Michael, Matthews, Metosh, Saunders, West and Appel (1995)
reported that LSD produced generalization to the negative isomer ofMDMA but not
the positive isomer. The results of the present study support the results of Oberlander
and Nichols (1988) and demonstrate the stimulus effects of LSD to be approximate to
those ofMDMA.
Fenfluramine, a relatively potent serotonin releaser, produced generalization
at a dose of 4.0 mg/kg. However, only two subjects out ofnine tested completed the
required ten responses. At the dose of 2.0 mg/kg, nearly complete substitution (75%)
was observed. Again, this lends support to the role ofserotonin in the discriminative
stimulus effects ofMDMA.
Further investigation of the role of serotonin in MDMA' s discriminative
stimulus effects in the present study demonstrated only partial antagonism ofMDMA
with the 5-HT2 antagonist pirenpirone. This finding is consistent with previous
reports that MDMA discrimination is only partially attenuated by 5-HT2 antagonists
(Schechter, 1989; Glennon et al. 1992; Baker et al. 1995). Thus, it may be concluded
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that the stimulus effects ofMDMA are not solely mediated by serotonin. However,
Glennon et al. (1992) found more complete antagonism with a 5-HT3 antagonists (i.e.,
zacopride and LY278584). Future investigations utilizing a three-choice
discrimination between MDMA and amphetamine could further evaluate 5-HT3
antagonists as well as other 5-HT antagonists.
The administration of both isomers ofMDA, a structural analog ofMDMA,
produced dose-dependent increases in MDMA appropriate responding. (+)-MDA
produced complete stimulus generalization at a dose of1.5 mg/kg and (-)-MDA
substituted at a dose of 3. 0 mg/kg. These findings are consistent with a previous
report by Baker et. al. (1995) that (+)-MDA exhibits stimulus generalization at lower
doses than (-)-MDA in rats trained to discriminate either isomer ofMDMA. These
findings also support those of Glennon and Young (1984) who reported that MDMA
produced stimulus generalization in rats trained to discriminate (±)-MDA. However,
Glennon and Young reported that (+)-MDA produced stimulus generalization to
amphetamine whereas (-)-MDA did not. Callahan and Appel (1988) reported that
(-)-MDA substituted for LSD while the administration of (+)-MDA produced saline
appropriate responding in rats trained to discriminate LSD from saline. Broadbent et
al. (1992) also reported that cl-amphetamine produced greater drug-appropriate
responding in rats trained to discriminate (+)-MDA from saline than in rats trained to
discriminate (-)-MDA from saline. Additionally, Broadbent et al. observed more
complete substitution with LSD for (-)-MDA than for (+)-MDA. Considered
together, the results ofthese four studies (Glennon and Young, 1984; Callahan and
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Appel 1988; Broadbent et al., 1992) suggest that the discriminative stimulus effects of
(+)-MDA approximate those ofamphetamine whereas the discriminative stimulus
effects of(-)-MDA are more similar to those ofLSD. However, the procedure used
in the present study may have provided a more sensitive measure ofthe stimulus
°

effects ofMDA. Neither isomer ofMDA produced stimulus effects similar to d
amphetamine in subjects trained to discriminate both MDMA and d-amphetamine.
Evans, Zacny, and Johanson (1990) trained pigeons to discriminate d
amphetamine, fenfluramine, and saline in a three-choice assay. Administration of
(+)-MDA, (-)-MDA, and (±)-MDMA produced responding on both the d
amphetamine-appropriate and fenfluarmine-appropriate keys. (+)-MDA produced
stimulus generalization to fenfluramine in two ofthe three pigeons tested.
Administration of (-)-MDA did not produce more than 70% on either key in any of
the three subjects. (±)-MDMA produced stimulus generalization to amphetamine in
two ofthe subjects.
In summary, the utilization ofa three-choice drug discrimination procedure
in the present study made it possible to dissociate the discriminative stimulus effects
ofd-amphetamine and MDMA in rats. Because d-amphetamine is known to exert its
stimulus effects primarily through dopaminergic actions, one conclusion may be that
the stimulus effects ofMDMA are not solely mediated through DA In this paradigm,
the discriminative stimulus control ofMDMA appeared to be maintained primarily by
serotonergic mechanisms. Future investigations should attempt to determine whether
the discriminative stimulus effects of LSD and MDMA can be dissociated using
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similar procedures. The goal of such investigations would be to assess whether
dopaminergic mechanisms would be more salient in mediating MDMA's
discriminative stimulus effects. If so, one might predict that d-amphetamine would
exhibit stimulus generalization to MDMA in such a procedure. Such findings, along
with the present results would lend support to the idea that MDMA should not be
classified into the traditional drug classes of stimulants or hallucinogens, but rather be
regarded as a distinct drug class (Nichols, 1986).

Appendix A
Protocol Clearance From the Institutional Animal
Care and Use Committee (IACUC)
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